3//SEC Filing
ADAR1 Partners, LP 3
Accession 0001758866-24-000005
CIK 0001583648other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 7:26 PM ET
Size
7.9 KB
Accession
0001758866-24-000005
Insider Transaction Report
Form 3
ADAR1 Capital Management, LLC
10% Owner
Holdings
- 14,310(indirect: By LLC)
Common Stock
- 124,331(indirect: By: ADAR1 Partners)
Common Stock
ADAR1 Partners, LP
10% Owner
Holdings
- 124,331(indirect: By: ADAR1 Partners)
Common Stock
- 14,310(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by ADAR1 Partners, LP ("ADAR1 Partners"). Because of the relationship between ADAR1 Partners and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by ADAR1 Partners.
- [F2]ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by Spearhead Insurance Solutions IDF, LLC - Series ADAR1 ("Spearhead"). Because of the relationship between Spearhead and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by Spearhead.
- [F3]For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001758866
Filing Metadata
- Form type
- 3
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 7:26 PM ET
- Size
- 7.9 KB